These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
733 related articles for article (PubMed ID: 32841605)
1. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor. Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L Cell Host Microbe; 2020 Oct; 28(4):586-601.e6. PubMed ID: 32841605 [TBL] [Abstract][Full Text] [Related]
2. Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor. Zhao P; Praissman JL; Grant OC; Cai Y; Xiao T; Rosenbalm KE; Aoki K; Kellman BP; Bridger R; Barouch DH; Brindley MA; Lewis NE; Tiemeyer M; Chen B; Woods RJ; Wells L bioRxiv; 2020 Jul; ():. PubMed ID: 32743578 [TBL] [Abstract][Full Text] [Related]
3. Enhanced Binding of SARS-CoV-2 Spike Protein to Receptor by Distal Polybasic Cleavage Sites. Qiao B; Olvera de la Cruz M ACS Nano; 2020 Aug; 14(8):10616-10623. PubMed ID: 32806067 [TBL] [Abstract][Full Text] [Related]
4. Coevolution, Dynamics and Allostery Conspire in Shaping Cooperative Binding and Signal Transmission of the SARS-CoV-2 Spike Protein with Human Angiotensin-Converting Enzyme 2. Verkhivker G Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33158276 [TBL] [Abstract][Full Text] [Related]
6. Development and simulation of fully glycosylated molecular models of ACE2-Fc fusion proteins and their interaction with the SARS-CoV-2 spike protein binding domain. Bernardi A; Huang Y; Harris B; Xiong Y; Nandi S; McDonald KA; Faller R PLoS One; 2020; 15(8):e0237295. PubMed ID: 32756606 [TBL] [Abstract][Full Text] [Related]
7. Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor. Yang J; Petitjean SJL; Koehler M; Zhang Q; Dumitru AC; Chen W; Derclaye S; Vincent SP; Soumillion P; Alsteens D Nat Commun; 2020 Sep; 11(1):4541. PubMed ID: 32917884 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 and bat RaTG13 spike glycoprotein structures inform on virus evolution and furin-cleavage effects. Wrobel AG; Benton DJ; Xu P; Roustan C; Martin SR; Rosenthal PB; Skehel JJ; Gamblin SJ Nat Struct Mol Biol; 2020 Aug; 27(8):763-767. PubMed ID: 32647346 [TBL] [Abstract][Full Text] [Related]
9. Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2. Liu Z; Xiao X; Wei X; Li J; Yang J; Tan H; Zhu J; Zhang Q; Wu J; Liu L J Med Virol; 2020 Jun; 92(6):595-601. PubMed ID: 32100877 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Severe Acute Respiratory Syndrome Coronavirus 2 Spike Protein Binding to ACE2 Receptors from Human, Pets, Farm Animals, and Putative Intermediate Hosts. Zhai X; Sun J; Yan Z; Zhang J; Zhao J; Zhao Z; Gao Q; He WT; Veit M; Su S J Virol; 2020 Jul; 94(15):. PubMed ID: 32404529 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of SARS-CoV-2 viral entry upon blocking N- and O-glycan elaboration. Yang Q; Hughes TA; Kelkar A; Yu X; Cheng K; Park S; Huang WC; Lovell JF; Neelamegham S Elife; 2020 Oct; 9():. PubMed ID: 33103998 [TBL] [Abstract][Full Text] [Related]
12. Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Grant OC; Montgomery D; Ito K; Woods RJ Sci Rep; 2020 Sep; 10(1):14991. PubMed ID: 32929138 [TBL] [Abstract][Full Text] [Related]
13. Structural basis of receptor recognition by SARS-CoV-2. Shang J; Ye G; Shi K; Wan Y; Luo C; Aihara H; Geng Q; Auerbach A; Li F Nature; 2020 May; 581(7807):221-224. PubMed ID: 32225175 [TBL] [Abstract][Full Text] [Related]
14. The Utility of Native MS for Understanding the Mechanism of Action of Repurposed Therapeutics in COVID-19: Heparin as a Disruptor of the SARS-CoV-2 Interaction with Its Host Cell Receptor. Yang Y; Du Y; Kaltashov IA Anal Chem; 2020 Aug; 92(16):10930-10934. PubMed ID: 32678978 [TBL] [Abstract][Full Text] [Related]
15. Identification of SARS-CoV-2 Cell Entry Inhibitors by Drug Repurposing Using Choudhary S; Malik YS; Tomar S Front Immunol; 2020; 11():1664. PubMed ID: 32754161 [TBL] [Abstract][Full Text] [Related]
16. Investigation of the genetic variation in ACE2 on the structural recognition by the novel coronavirus (SARS-CoV-2). Guo X; Chen Z; Xia Y; Lin W; Li H J Transl Med; 2020 Aug; 18(1):321. PubMed ID: 32831104 [TBL] [Abstract][Full Text] [Related]
17. Broad and Differential Animal Angiotensin-Converting Enzyme 2 Receptor Usage by SARS-CoV-2. Zhao X; Chen D; Szabla R; Zheng M; Li G; Du P; Zheng S; Li X; Song C; Li R; Guo JT; Junop M; Zeng H; Lin H J Virol; 2020 Aug; 94(18):. PubMed ID: 32661139 [TBL] [Abstract][Full Text] [Related]
18. Hot spot profiles of SARS-CoV-2 and human ACE2 receptor protein protein interaction obtained by density functional tight binding fragment molecular orbital method. Lim H; Baek A; Kim J; Kim MS; Liu J; Nam KY; Yoon J; No KT Sci Rep; 2020 Oct; 10(1):16862. PubMed ID: 33033344 [TBL] [Abstract][Full Text] [Related]
19. Optimized Pseudotyping Conditions for the SARS-COV-2 Spike Glycoprotein. Johnson MC; Lyddon TD; Suarez R; Salcedo B; LePique M; Graham M; Ricana C; Robinson C; Ritter DG J Virol; 2020 Oct; 94(21):. PubMed ID: 32788194 [TBL] [Abstract][Full Text] [Related]
20. Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus. Wan Y; Shang J; Graham R; Baric RS; Li F J Virol; 2020 Mar; 94(7):. PubMed ID: 31996437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]